peptide research raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-09-08 and is reviewed periodically as new material appears.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
Both specialties are important to address a child's milestone development and disease treatment throughout childhood. However, recognition of this sub-specialty has been slow, which has resulted in a global shortage of pediatric rheumatologists, and as a consequence, the demand for healthcare support far exceeds current service capacities. Raising awareness of this is important to attract more upcoming pediatricians into this rewarding area of healthcare.
=== Therapy studies === Due to the rarity of the disease, many important questions about adrenocortical carcinoma remain unanswered. Therefore, as many patients as possible should be treated in registry studies or therapy studies.
===== Group D1 – Halogenated (less labile) ===== Alclometasone dipropionate, betamethasone dipropionate, betamethasone valerate, clobetasol propionate, clobetasone butyrate, fluprednidene acetate, and mometasone furoate.
Sources: en.wikipedia.org
25 February The North Vietnamese Foreign Ministry on Radio Hanoi stated that the "South Vietnamese people" could attack U.S. forces "at any place on Vietnamese territory" and denied that there was any agreement not to conduct such attacks in return for the bombing halt.
== History == The dope testing Lab in India was established in 1990 (as Dope control Centre under the Sports Authority of India). The lab was modernized in 2002 with an aim to get it permanently accredited by International Olympic Commission and WADA. The lab got ISO/IEC 17025 accreditation in 2003 : An eligibility criteria for applying for WADA accreditation. Since Sports Authority of India is responsible for training of elite athletes, hence in view of conflict of interest, a decision was taken to have the independent body responsible for managing the Anti Doping Program in the country. The Union Cabinet took a decision to sign the Copenhagen declaration on anti doping and to set up National Anti Doping Agency in December 2004. The first meeting of General Body/Governing Body of NDTL was held under the Chairmanship of then Honourable Minister Youth Affairs & Sports M.S. Gill on 5th Jan. 2009. The recruitment rules, tariff for dope testing, action plan for Common Wealth Games 2010 was duly approved by the Governing Body.
Widespread use Spironolactone — the first and most widely used member of this class Eplerenone — much more selective than spironolactone on target, but somewhat less potent and efficacious Uncommon use (to date) Canrenone and potassium canrenoate — very limited use Finerenone — nonsteroidal and more potent and selective than either eplerenone or spironolactone Some drugs also have antimineralocorticoid effects secondary to their main mechanism of actions. Examples include progesterone, drospirenone, gestodene, metribolone, and benidipine.
== Career == He joined the Department of Pharmacology of Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, on 14 April 1964 as Professor and Founder Chairman Department of Pharmacology. He served a period as Head Department of Pharmacology till 30 September 1985 and in view of his outstanding merits, he was re-employed by the University for the two years to 30 September 1987. Soon after retirement, he was selected as emeritus scientist of the ICMR, New Delhi, for a period from 1 September 1987, which he served till 14 September 1990. On 31 January 1991, the University appointed him as professor emeritus. In the university, he had also acted as Dean, Faculty of Medicine, In-charge, Animal House and on few occasions as acting Principal Ajmal Khan Tibbiya College and acting Vice Chancellor of the University. As a Professor Emeritus, he continued his active research in the Department of Pharmacology till late December 1994.
Sources: en.wikipedia.org
Moreover, although it has been established that ethanol modulates ion channels to mediate its effects, ion channels are complex proteins, and their interactions and functions are complicated by diverse subunit compositions and regulation by conserved cellular signals (e.g. signaling lipids). Alcohol is also converted into phosphatidylethanol (PEth, an unnatural lipid metabolite) by phospholipase D2. This metabolite competes with PIP2 agonist sites on lipid-gated ion channels. The result of these direct effects is a wave of further indirect effects involving a variety of other neurotransmitter and neuropeptide systems. This presents a novel indirect mechanism and suggests that a metabolite, not the ethanol itself, could cause the behavioural or symptomatic effects of alcohol intoxication. Many of the primary targets of ethanol are known to bind PIP2 including GABAA receptors, but the role of PEth needs to be investigated further.
There are several techniques to produce peptides chemically, generally it is by solid-phase protection chemistry. This means that any (protected) amino acid can be added into the nascent sequence. In November 2017, a team from the Scripps Research Institute reported having constructed a semi-synthetic E. coli bacteria genome using six different nucleotides (versus four found in nature). The two extra 'letters' form a third, unnatural base pair. The resulting organisms were able to thrive and synthesize proteins using "unnatural amino acids". The unnatural base pair used is dNaM–dTPT3. This unnatural base pair has been demonstrated previously, but this is the first report of transcription and translation of proteins using an unnatural base pair.
The cost of the war to the United States was calculated by the US Congress in April 1992 to be $61.1 billion (equivalent to $122 billion in 2024). About $52 billion of that amount was paid by other countries. $36 billion by Kuwait, Saudi Arabia and other Arab states of the Persian Gulf. $16 billion were contributed by Germany and Japan, which sent no combat forces due to their constitutions. About 25% of Saudi Arabia's contribution was paid with in-kind services to the troops, such as food and transportation. US troops represented about 74% of the combined force, and the global cost was therefore higher.
== Control == Some cultural practices are effective in managing this disease. Cultural methods include antibacterial management, sanitation, removal of infected plants, frequent scouting, and most importantly, crisis declaration. Tracking the disease can help prevent further infection in other affected areas and help mitigate more local infections, if detected early enough. The Asian citrus psyllid has alternative hosts that may attract psyllids to citrus plants in the vicinity such as Murraya paniculata, Severinia buxifolia, and other plants in the family Rutaceae. No cure for citrus greening disease is known, and efforts to control it have been slow because infected citrus plants are difficult to maintain, regenerate, and study. Ongoing challenges associated with mitigating disease at the field-scale include seasonality of the phytopathogen (Liberibacter spp.) and associated disease symptoms, limitations for therapeutics to contact the phytopathogen in planta, adverse impacts of broad-spectrum treatments on plant-beneficial microbiota, and potential implications on public and ecosystem health. The effort to culture Candidatus Liberibacter asiaticus (CLas) has been a significant challenge in plant pathology. Progress has included culturing a different species of Liberibacter. No naturally immune citrus cultivars have been identified. Creating genetically modified citrus may be a possible solution, but questions of its acceptability to consumers exist.
== Mechanical stress and activity indicators == Examining the effects that activities has upon the skeleton allows the archaeologist to examine who was doing what kinds of labor, and how activities were structured within society. Labor within the household may be divided according to gender and age, or be based on other social structures. Human remains can allow archaeologists to uncover these patterns. Living bones are subject to Wolff's law, which states that bones are physically affected and remodeled by physical activity or inactivity. Increases in mechanical stress tend to produce thicker and stronger bones. Disruptions in homeostasis caused by nutritional deficiency or disease or profound inactivity/disuse/disability can lead to bone loss. While the acquisition of bipedal locomotion and body mass appear to determine the size and shape of children's bones, activity during the adolescent growth period seems to exert a greater influence on the size and shape of adult bones than exercise later in life. Muscle or ligament attachment sites on bones (entheses) are also considered to be impacted by habitual biomechanical loading, leading to the occurrence of various entheseal changes. These changes are routinely used in the field to study activity-patterns.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.